The protein and mRNA levels of the hypertrophic marker ANP were increased while MYH6 was decreased (Fig. 1F, G), demonstrating that HFD-induced cardiac hypertrophy model was successfully established. The gene discussed is NPPA; the disease is cardiac hypertrophy.